Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.3 trillion and total revenue of $109.84 billion.
Market Cap
1.3T
Revenue
109.84B
Profits
-41.29B
PE Ratio
n/a
Profit Margin
-37.59%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 123.43B | -2.43% | 716,193 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 67.64B | 0.29% | 199,628 | 14.92B |
| 3 | ARGX | argenx SE | 56.71B | -0.75% | 156,061 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 44.35B | 2.69% | 3,833,480 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 40.99B | 1.60% | 533,363 | - |
| 6 | ONC | BeOne Medicines AG | 33.77B | 0.62% | 50,727 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 33.38B | -0.70% | 1,086,058 | 2.44B |
| 8 | MRNA | Moderna, Inc. | 30.08B | 2.71% | 1,958,265 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.08B | 0.47% | 1,469,605 | 8.26M |
| 10 | INSM | Insmed Incorporated | 25.65B | 1.55% | 890,203 | 819.56M |
| 11 | BNTX | BioNTech SE | 23.60B | -0.22% | 203,700 | 3.23B |
| 12 | INCY | Incyte Corporation | 23.51B | 0.38% | 433,080 | 5.36B |
| 13 | GMAB | Genmab A/S | 17.71B | -0.32% | 1,702,310 | 3.90B |
| 14 | BBIO | BridgeBio Pharma, Inc. | 17.61B | 14.69% | 9,909,547 | 579.96M |
| 15 | ASND | Ascendis Pharma A/S | 17.31B | 0.55% | 287,094 | 998.25M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.59B | -0.04% | 182,475 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 14.27B | 1.16% | 542,155 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.71B | -2.52% | 76,381 | 1.13B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.63B | -0.05% | 180,132 | 708.24M |
| 20 | SMMT | Summit Therapeutics Inc. | 12.15B | -0.25% | 750,858 | - |
| 21 | ABVX | ABIVAX Société Anonyme | 12.00B | 1.86% | 533,955 | 5.67M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.99B | -0.75% | 379,235 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 11.54B | -0.12% | 223,923 | 3.24B |
| 24 | CYTK | Cytokinetics, Incorporated | 11.37B | -1.35% | 401,954 | 105.82M |
| 25 | TECH | Bio-Techne Corporation | 11.09B | 0.29% | 1,521,284 | 1.21B |
| 26 | KRYS | Krystal Biotech, Inc. | 10.83B | -2.18% | 95,978 | 417.30M |
| 27 | IONS | Ionis Pharmaceuticals, Inc. | 10.78B | -22.74% | 11,943,482 | 1.06B |
| 28 | CORT | Corcept Therapeutics Incorporated | 10.15B | 1.74% | 274,694 | 769.10M |
| 29 | APGE | Apogee Therapeutics, Inc. | 10.00B | 0.11% | 535,819 | - |
| 30 | NUVL | Nuvalent, Inc. | 9.82B | 0.01% | 950,897 | - |
| 31 | KYMR | Kymera Therapeutics, Inc. | 9.51B | 1.26% | 154,150 | 51.48M |
| 32 | PRAX | Praxis Precision Medicines, Inc. | 9.40B | 1.27% | 84,192 | 7.46M |
| 33 | HALO | Halozyme Therapeutics, Inc. | 9.39B | -1.48% | 740,162 | 1.51B |
| 34 | IBRX | ImmunityBio, Inc. | 9.15B | -0.68% | 5,089,946 | 140.98M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 8.90B | -1.24% | 153,711 | 74.06M |
| 36 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.81B | 0.06% | 5,242,160 | 18.07M |
| 37 | PCVX | Vaxcyte, Inc. | 8.56B | 0.99% | 494,133 | - |
| 38 | SYRE | Spyre Therapeutics, Inc. | 8.43B | 1.81% | 453,059 | - |
| 39 | IMVT | Immunovant, Inc. | 8.39B | 1.34% | 361,237 | - |
| 40 | TGTX | TG Therapeutics, Inc. | 8.33B | 2.76% | 455,142 | 700.35M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.87B | 0.33% | 165,012 | 217.17M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 7.77B | -0.89% | 167,730 | 569.61M |
| 43 | PTCT | PTC Therapeutics, Inc. | 7.39B | 0.64% | 360,929 | 827.11M |
| 44 | COGT | Cogent Biosciences, Inc. | 6.98B | 2.15% | 2,083,677 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 6.88B | 2.53% | 326,693 | - |
| 46 | XENE | Xenon Pharmaceuticals Inc. | 6.70B | -0.91% | 1,120,121 | 7.50M |
| 47 | CGON | CG Oncology, Inc. | 6.46B | 4.91% | 306,707 | 5.07M |
| 48 | DFTX | Definium Therapeutics, Inc. | 6.40B | 6.42% | 1,582,846 | - |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 6.27B | 0.50% | 99,371 | 274.48M |
| 50 | ERAS | Erasca, Inc. | 6.05B | 3.18% | 1,196,485 | - |
| 51 | BLTE | Belite Bio, Inc | 5.97B | -0.29% | 50,894 | - |
| 52 | CRSP | CRISPR Therapeutics AG | 5.52B | -3.31% | 574,243 | 4.10M |
| 53 | DNTH | Dianthus Therapeutics, Inc. | 5.44B | 1.46% | 487,438 | 1.34M |
| 54 | TVTX | Travere Therapeutics, Inc. | 5.43B | - | 335,478 | 536.20M |
| 55 | CELC | Celcuity Inc. | 5.41B | 1.85% | 509,274 | - |
| 56 | LEGN | Legend Biotech Corporation | 5.39B | - | 741,797 | 1.14B |
| 57 | ORKA | Oruka Therapeutics, Inc. | 5.25B | 3.14% | 250,164 | - |
| 58 | MANE | Veradermics, Incorporated | 5.19B | 5.03% | 133,867 | - |
| 59 | CAI | Caris Life Sciences, Inc. | 5.19B | 5.95% | 1,533,861 | 907.29M |
| 60 | EWTX | Edgewise Therapeutics, Inc. | 5.06B | 1.60% | 636,367 | - |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.66B | 0.50% | 718,038 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 4.46B | 0.23% | 528,623 | 1.10B |
| 63 | RLAY | Relay Therapeutics, Inc. | 4.40B | 2.90% | 965,767 | 10.68M |
| 64 | TNGX | Tango Therapeutics, Inc. | 4.40B | -0.69% | 758,230 | 56.99M |
| 65 | DNLI | Denali Therapeutics Inc. | 4.25B | 0.30% | 564,680 | - |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 4.16B | -0.59% | 233,904 | 22.57M |
| 67 | PBLS | Parabilis Medicines, Inc. | 4.00B | 1.85% | 142,098 | - |
| 68 | DYN | Dyne Therapeutics, Inc. | 3.99B | 1.26% | 443,239 | - |
| 69 | TLX | Telix Pharmaceuticals Limited | 3.97B | 2.34% | 91,151 | 803.79M |
| 70 | GPCR | Structure Therapeutics Inc. | 3.88B | -0.62% | 216,356 | - |
| 71 | ALMS | Alumis Inc. | 3.87B | 2.05% | 605,109 | 8.40M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | - | 242,490 | 596.96M |
| 73 | RCUS | Arcus Biosciences, Inc. | 3.78B | -0.69% | 193,779 | 236.00M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 3.60B | -0.37% | 164,856 | 225.27M |
| 75 | BEAM | Beam Therapeutics Inc. | 3.59B | -2.30% | 1,071,813 | 164.01M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.58B | 0.46% | 584,169 | 415.62M |
| 77 | ELVN | Enliven Therapeutics, Inc. | 3.52B | -0.85% | 184,736 | - |
| 78 | RARE | Ultragenyx Pharmaceutical Inc. | 3.38B | -0.78% | 821,808 | 670.00M |
| 79 | IRON | Disc Medicine, Inc. | 3.05B | -0.20% | 89,223 | - |
| 80 | MBX | MBX Biosciences, Inc. | 3.05B | 3.68% | 323,037 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 3.05B | -0.39% | 172,240 | 865.00K |
| 82 | VERA | Vera Therapeutics, Inc. | 3.01B | -1.32% | 993,714 | - |
| 83 | QURE | uniQure N.V. | 2.99B | 0.09% | 609,754 | 18.09M |
| 84 | IMNM | Immunome, Inc. | 2.78B | 2.12% | 362,819 | 4.02M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.69B | -0.51% | 2,126,624 | - |
| 86 | KLRA | Kailera Therapeutics, Inc. | 2.68B | -4.78% | 303,054 | - |
| 87 | TARS | Tarsus Pharmaceuticals, Inc. | 2.66B | -8.76% | 1,051,913 | 535.08M |
| 88 | TRVI | Trevi Therapeutics, Inc. | 2.63B | -0.54% | 453,028 | - |
| 89 | MLYS | Mineralys Therapeutics, Inc. | 2.56B | -4.31% | 559,733 | - |
| 90 | NRIX | Nurix Therapeutics, Inc. | 2.55B | 1.52% | 394,517 | 71.78M |
| 91 | PHVS | Pharvaris N.V. | 2.52B | 0.53% | 1,025,060 | - |
| 92 | KOD | Kodiak Sciences Inc. | 2.51B | -1.01% | 321,096 | - |
| 93 | AGIO | Agios Pharmaceuticals, Inc. | 2.51B | -1.44% | 156,977 | 66.05M |
| 94 | BHVN | Biohaven Ltd. | 2.50B | -0.36% | 726,270 | - |
| 95 | NKTR | Nektar Therapeutics | 2.47B | 1.74% | 184,046 | 55.63M |
| 96 | VCEL | Vericel Corporation | 2.44B | 1.75% | 131,365 | 292.09M |
| 97 | OCUL | Ocular Therapeutix, Inc. | 2.28B | 1.46% | 801,273 | 52.04M |
| 98 | ZLAB | Zai Lab Limited | 2.25B | 1.37% | 373,328 | 453.28M |
| 99 | ABCL | AbCellera Biologics Inc. | 2.23B | 2.96% | 3,841,270 | 79.21M |
| 100 | VRDN | Viridian Therapeutics, Inc. | 2.23B | 1.64% | 1,085,434 | 70.92M |
| 101 | SNDX | Syndax Pharmaceuticals, Inc. | 2.19B | 0.86% | 420,935 | 217.17M |
| 102 | HRMY | Harmony Biosciences Holdings, Inc. | 2.18B | -1.34% | 200,472 | 899.11M |
| 103 | NTLA | Intellia Therapeutics, Inc. | 2.17B | -7.96% | 4,146,023 | 66.09M |
| 104 | PVLA | Palvella Therapeutics, Inc. | 2.15B | 3.45% | 40,717 | - |
| 105 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | 2.40% | 405,970 | 298.30M |
| 106 | NUVB | Nuvation Bio Inc. | 2.13B | 4.34% | 3,238,782 | 143.05M |
| 107 | SRPT | Sarepta Therapeutics, Inc. | 2.12B | -0.45% | 1,331,898 | 2.18B |
| 108 | ADMA | ADMA Biologics, Inc. | 2.11B | -0.66% | 528,432 | 509.86M |
| 109 | TSHA | Taysha Gene Therapies, Inc. | 2.07B | -0.46% | 577,322 | 7.47M |
| 110 | KARD | Kardigan, Inc. | 2.06B | 3.85% | 109,098 | - |
| 111 | GLUE | Monte Rosa Therapeutics, Inc. | 2.06B | 1.29% | 546,465 | 42.95M |
| 112 | STOK | Stoke Therapeutics, Inc. | 2.04B | 0.46% | 116,170 | 32.08M |
| 113 | SION | Sionna Therapeutics, Inc. | 2.03B | 2.16% | 328,238 | - |
| 114 | LKFT | Lakefront Biotherapeutics NV | 2.01B | -0.71% | 52,858 | 1.20B |
| 115 | RAPP | Rapport Therapeutics, Inc. | 2.00B | -0.23% | 109,593 | 20.00M |
| 116 | RXRX | Recursion Pharmaceuticals, Inc. | 2.00B | 1.34% | 9,945,928 | 66.41M |
| 117 | GENB | Generate Biomedicines, Inc. | 2.00B | -1.83% | 253,092 | 30.30M |
| 118 | PGEN | Precigen, Inc. | 1.99B | 0.18% | 1,002,277 | 31.60M |
| 119 | IOVA | Iovance Biotherapeutics, Inc. | 1.98B | 3.74% | 8,319,509 | 285.61M |
| 120 | ATAI | AtaiBeckley Inc. | 1.96B | 3.09% | 4,039,008 | 3.49M |
| 121 | BCAX | Bicara Therapeutics Inc. | 1.94B | 1.93% | 120,782 | - |
| 122 | ZYME | Zymeworks Inc. | 1.94B | 1.50% | 176,737 | 81.26M |
| 123 | NBTX | Nanobiotix S.A. | 1.93B | 0.52% | 21,693 | 38.27M |
| 124 | TYRA | Tyra Biosciences, Inc. | 1.93B | -0.52% | 190,552 | - |
| 125 | ABSI | Absci Corporation | 1.91B | 1.44% | 2,773,511 | 1.84M |
| 126 | ANAB | AnaptysBio, Inc. | 1.91B | -1.44% | 122,050 | 232.39M |
| 127 | URGN | UroGen Pharma Ltd. | 1.90B | 2.55% | 162,139 | 140.49M |
| 128 | MESO | Mesoblast Limited | 1.88B | -0.07% | 132,197 | 65.38M |
| 129 | GHRS | GH Research PLC | 1.85B | 0.26% | 61,978 | - |
| 130 | ZBIO | Zenas BioPharma, Inc. | 1.84B | 1.51% | 176,984 | 10.00M |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.80B | 1.94% | 133,916 | 20.00M |
| 132 | DMRA | Damora Therapeutics, Inc. | 1.78B | 5.16% | 278,121 | - |
| 133 | MPLT | MapLight Therapeutics, Inc. | 1.76B | 0.65% | 401,784 | - |
| 134 | VIR | Vir Biotechnology, Inc. | 1.73B | -1.73% | 461,258 | 65.50M |
| 135 | COAG | Hemab Therapeutics Holdings, Inc. | 1.71B | 7.85% | 90,318 | - |
| 136 | SEPN | Septerna, Inc. | 1.68B | 2.66% | 256,051 | 72.26M |
| 137 | IMCR | Immunocore Holdings plc | 1.68B | -2.43% | 262,248 | 412.81M |
| 138 | FTRE | Fortrea Holdings Inc. | 1.67B | 4.00% | 245,992 | 2.71B |
| 139 | MLTX | MoonLake Immunotherapeutics | 1.64B | 3.88% | 614,810 | - |
| 140 | INVA | Innoviva, Inc. | 1.63B | -1.25% | 150,842 | 420.69M |
| 141 | AKTS | Aktis Oncology, Inc. | 1.61B | 1.31% | 143,195 | 8.28M |
| 142 | AAPG | Ascentage Pharma Group International | 1.60B | -1.67% | 1,552 | 82.08M |
| 143 | SVRA | Savara Inc. | 1.58B | -2.51% | 578,196 | - |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.57B | 0.85% | 137,275 | - |
| 145 | INBX | Inhibrx Biosciences, Inc. | 1.56B | 9.53% | 322,230 | 1.30M |
| 146 | NVAX | Novavax, Inc. | 1.55B | 0.86% | 1,412,768 | 596.34M |
| 147 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.54B | 3.65% | 506,052 | 204.73M |
| 148 | CRVS | Corvus Pharmaceuticals, Inc. | 1.37B | 1.24% | 342,080 | - |
| 149 | IMTX | Immatics N.V. | 1.35B | -1.20% | 105,098 | 43.00M |
| 150 | JBIO | Jade Biosciences, Inc. | 1.33B | -0.58% | 240,970 | - |
| 151 | ARDX | Ardelyx, Inc. | 1.33B | -1.10% | 725,426 | 427.68M |
| 152 | MNKD | MannKind Corporation | 1.30B | -1.06% | 1,013,180 | 360.78M |
| 153 | AVLN | Avalyn Pharma Inc. | 1.28B | -0.43% | 22,572 | - |
| 154 | CAPR | Capricor Therapeutics, Inc. | 1.27B | -1.75% | 438,160 | 11.13M |
| 155 | MGTX | MeiraGTx Holdings plc | 1.25B | -4.21% | 408,723 | 79.76M |
| 156 | EYPT | EyePoint, Inc. | 1.24B | 5.57% | 602,931 | 7.61M |
| 157 | XNCR | Xencor, Inc. | 1.20B | -2.07% | 190,123 | 97.36M |
| 158 | WVE | Wave Life Sciences Ltd. | 1.19B | -0.96% | 650,837 | 71.80M |
| 159 | DRTS | Alpha Tau Medical Ltd. | 1.18B | 2.11% | 220,695 | - |
| 160 | SANA | Sana Biotechnology, Inc. | 1.17B | -2.39% | 977,363 | - |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.13B | 0.18% | 218,849 | - |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 1.12B | -0.98% | 206,410 | - |
| 163 | VOR | Vor Biopharma Inc. | 1.09B | -1.23% | 694,127 | - |
| 164 | SLDB | Solid Biosciences Inc. | 1.08B | - | 388,157 | - |
| 165 | OLMA | Olema Pharmaceuticals, Inc. | 1.07B | 0.24% | 380,727 | - |
| 166 | KURA | Kura Oncology, Inc. | 1.06B | -1.73% | 502,646 | 71.64M |
| 167 | SPTX | Seaport Therapeutics, Inc. | 1.05B | -7.67% | 24,521 | - |
| 168 | AVTX | Avalo Therapeutics, Inc. | 1.03B | 2.45% | 311,086 | 59.00K |
| 169 | TRAX | First Tracks Biotherapeutics, Inc. | 1.03B | 42.51% | 2,049,306 | - |
| 170 | ABUS | Arbutus Biopharma Corporation | 1.03B | -0.57% | 1,197,315 | 191.45M |
| 171 | GERN | Geron Corporation | 1.02B | 1.92% | 5,694,231 | 196.12M |
| 172 | IVA | Inventiva S.A. | 1.01B | -1.94% | 815,563 | 7.94M |
| 173 | PHAR | Pharming Group N.V. | 1.01B | 0.84% | 1,097 | 369.49M |
| 174 | JANX | Janux Therapeutics, Inc. | 1.01B | -0.42% | 305,475 | 13.73M |
| 175 | LXRX | Lexicon Pharmaceuticals, Inc. | 990.56M | -1.76% | 554,618 | 69.64M |
| 176 | DBVT | DBV Technologies S.A. | 971.65M | -2.45% | 48,294 | 5.74M |
| 177 | ANNX | Annexon, Inc. | 960.94M | -1.59% | 664,614 | - |
| 178 | LBRX | LB Pharmaceuticals Inc | 955.08M | -2.53% | 102,861 | - |
| 179 | PHAT | Phathom Pharmaceuticals, Inc. | 946.01M | -1.24% | 1,097,499 | 204.89M |
| 180 | ANRO | Alto Neuroscience, Inc. | 945.43M | 3.26% | 137,057 | - |
| 181 | DSGN | Design Therapeutics, Inc. | 939.35M | -1.57% | 166,719 | - |
| 182 | REPL | Replimune Group, Inc. | 932.21M | -0.13% | 1,128,854 | - |
| 183 | TENX | Tenax Therapeutics, Inc. | 918.12M | 1.35% | 825,607 | - |
| 184 | TBPH | Theravance Biopharma, Inc. | 881.08M | - | 155,577 | 109.78M |
| 185 | ZVRA | Zevra Therapeutics, Inc. | 840.03M | -3.66% | 496,190 | 122.29M |
| 186 | CTMX | CytomX Therapeutics, Inc. | 824.01M | -1.17% | 544,803 | 35.54M |
| 187 | OCS | Oculis Holding AG | 823.09M | -0.51% | 141,858 | 1.40M |
| 188 | ODTX | Odyssey Therapeutics, Inc. | 811.05M | 8.87% | 38,007 | 1.06M |
| 189 | ACRS | Aclaris Therapeutics, Inc. | 805.86M | 4.72% | 995,658 | 8.37M |
| 190 | FTH | Faeth Therapeutics, Inc. | 804.04M | 11.31% | 77,824 | - |
| 191 | NGNE | Neurogene Inc. | 802.76M | 5.35% | 114,921 | 925.00K |
| 192 | RIGL | Rigel Pharmaceuticals, Inc. | 798.83M | 0.57% | 107,599 | 299.77M |
| 193 | PRME | Prime Medicine, Inc. | 794.72M | -4.76% | 2,203,500 | 4.03M |
| 194 | IMMX | Immix Biopharma, Inc. | 787.36M | 0.55% | 479,896 | - |
| 195 | SPRY | ARS Pharmaceuticals, Inc. | 785.49M | -2.35% | 438,507 | 98.99M |
| 196 | RGNX | REGENXBIO Inc. | 776.00M | -1.44% | 816,842 | 87.82M |
| 197 | AURA | Aura Biosciences, Inc. | 768.79M | -3.86% | 217,340 | - |
| 198 | CLYM | Climb Bio, Inc. | 765.00M | -1.55% | 288,949 | - |
| 199 | FBRX | Forte Biosciences, Inc. | 763.13M | 51.75% | 2,541,826 | - |
| 200 | MNPR | Monopar Therapeutics Inc. | 742.89M | 11.72% | 216,151 | - |
| 201 | OMER | Omeros Corporation | 737.50M | -0.49% | 345,473 | 9.89M |
| 202 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 735.38M | 1.77% | 180,513 | - |
| 203 | CADL | Candel Therapeutics, Inc. | 725.38M | 0.20% | 432,856 | - |
| 204 | ALLO | Allogene Therapeutics, Inc. | 721.37M | -1.42% | 2,625,816 | 22.00K |
| 205 | SLBT | SL Science Holding Limited | 695.00M | -0.92% | 17,903 | - |
| 206 | CRMD | CorMedix Inc. | 684.89M | -1.13% | 257,022 | 400.05M |
| 207 | SGP | SpyGlass Pharma, Inc. | 681.04M | -0.44% | 37,785 | - |
| 208 | RLMD | Relmada Therapeutics, Inc. | 677.59M | 0.78% | 352,816 | - |
| 209 | FDMT | 4D Molecular Therapeutics, Inc. | 670.70M | -1.46% | 182,447 | 88.24M |
| 210 | DRUG | Bright Minds Biosciences Inc. | 663.93M | 4.94% | 111,950 | - |
| 211 | TECX | Tectonic Therapeutic, Inc. | 663.06M | -0.96% | 77,296 | - |
| 212 | ACHV | Achieve Life Sciences, Inc. | 634.43M | -0.48% | 305,687 | - |
| 213 | AGMB | AgomAb Therapeutics NV | 631.11M | 0.59% | 36,276 | - |
| 214 | GYRE | Gyre Therapeutics, Inc. | 627.21M | 0.06% | 23,000 | 117.05M |
| 215 | EIKN | Eikon Therapeutics, Inc. | 625.57M | 7.79% | 190,080 | - |
| 216 | MDXG | MiMedx Group, Inc. | 611.42M | -3.64% | 375,466 | 389.42M |
| 217 | DNA | Ginkgo Bioworks Holdings, Inc. | 604.25M | 1.98% | 407,338 | 151.40M |
| 218 | ALT | Altimmune, Inc. | 598.01M | -1.13% | 1,040,177 | 36.00K |
| 219 | KYTX | Kyverna Therapeutics, Inc. | 595.79M | -1.11% | 402,145 | - |
| 220 | NVCT | Nuvectis Pharma, Inc. | 594.57M | 0.59% | 105,150 | - |
| 221 | CTNM | Contineum Therapeutics, Inc. | 577.99M | -1.21% | 68,773 | - |
| 222 | ASMB | Assembly Biosciences, Inc. | 559.74M | -1.69% | 62,617 | 71.10M |
| 223 | XOMA | XOMA Royalty Corporation | 555.44M | -1.58% | 90,686 | 48.56M |
| 224 | CBIO | Crescent Biopharma, Inc. | 553.93M | -0.83% | 24,369 | 11.88M |
| 225 | ARVN | Arvinas, Inc. | 546.49M | -1.05% | 198,767 | 89.40M |
| 226 | PROK | ProKidney Corp. | 537.67M | -3.26% | 585,468 | 889.00K |
| 227 | STTK | Shattuck Labs, Inc. | 536.00M | 1.60% | 232,834 | 1.00M |
| 228 | STRO | Sutro Biopharma, Inc. | 525.53M | -0.39% | 51,000 | 99.61M |
| 229 | RZLT | Rezolute, Inc. | 523.90M | 1.11% | 368,086 | - |
| 230 | EDIT | Editas Medicine, Inc. | 523.30M | -7.08% | 1,377,079 | 38.69M |
| 231 | PRTA | Prothena Corporation plc | 506.78M | -1.73% | 189,157 | 57.94M |
| 232 | ZURA | Zura Bio Limited | 500.64M | -4.01% | 385,852 | - |
| 233 | OVID | Ovid Therapeutics Inc. | 500.20M | -1.83% | 594,220 | 7.12M |
| 234 | CABA | Cabaletta Bio, Inc. | 497.32M | -2.56% | 1,897,421 | - |
| 235 | PRLD | Prelude Therapeutics Incorporated | 493.90M | -2.73% | 133,977 | 16.72M |
| 236 | VALN | Valneva SE | 493.63M | -0.09% | 7,541 | 180.25M |
| 237 | EVMN | Evommune, Inc. | 488.41M | 2.34% | 632,478 | 10.00M |
| 238 | OCGN | Ocugen, Inc. | 482.39M | -5.00% | 2,171,887 | 4.47M |
| 239 | CCCC | C4 Therapeutics, Inc. | 477.65M | 3.10% | 1,151,982 | 34.86M |
| 240 | SLN | Silence Therapeutics plc | 474.23M | 0.90% | 101,948 | 839.00K |
| 241 | BNTC | Benitec Biopharma Inc. | 459.66M | -0.74% | 15,057 | - |
| 242 | VSTM | Verastem, Inc. | 459.58M | 2.95% | 1,780,662 | 49.59M |
| 243 | ARTV | Artiva Biotherapeutics, Inc. | 457.70M | 1.18% | 119,984 | 251.00K |
| 244 | EPRX | Eupraxia Pharmaceuticals Inc. | 451.39M | -0.58% | 45,985 | - |
| 245 | SGMT | Sagimet Biosciences Inc. | 448.32M | -2.42% | 163,755 | - |
| 246 | RCKT | Rocket Pharmaceuticals, Inc. | 445.51M | -3.77% | 806,270 | - |
| 247 | AUTL | Autolus Therapeutics plc | 437.81M | -3.24% | 410,456 | 92.62M |
| 248 | LRMR | Larimar Therapeutics, Inc. | 429.54M | 13.99% | 2,091,011 | - |
| 249 | DMAC | DiaMedica Therapeutics Inc. | 425.68M | -0.75% | 57,655 | - |
| 250 | UPB | Upstream Bio, Inc. | 419.03M | -3.51% | 104,821 | 3.32M |
| 251 | VTVT | vTv Therapeutics Inc. | 418.57M | -2.60% | 22,108 | 36.84M |
| 252 | ANL | Adlai Nortye Ltd. | 417.60M | 2.55% | 82,108 | 5.00M |
| 253 | IPSC | Century Therapeutics, Inc. | 416.62M | -4.94% | 466,713 | 109.16M |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 415.53M | -1.38% | 47,110 | 69.21M |
| 255 | CMPX | Compass Therapeutics, Inc. | 412.40M | -2.14% | 1,087,624 | 850.00K |
| 256 | PBYI | Puma Biotechnology, Inc. | 401.09M | -3.08% | 210,436 | 227.18M |
| 257 | ABEO | Abeona Therapeutics Inc. | 397.26M | 2.50% | 1,481,046 | 14.54M |
| 258 | AVIR | Atea Pharmaceuticals, Inc. | 392.93M | 2.08% | 126,368 | - |
| 259 | LXEO | Lexeo Therapeutics, Inc. | 392.61M | -5.30% | 462,559 | - |
| 260 | VCRE | Vicore Pharma Holding AB (publ) | 386.95M | -6.22% | 13,628 | 370.61K |
| 261 | HELP | Cybin Inc. | 383.68M | -0.64% | 416,437 | - |
| 262 | VNDA | Vanda Pharmaceuticals Inc. | 380.36M | -3.88% | 292,803 | 217.78M |
| 263 | XFOR | X4 Pharmaceuticals, Inc. | 373.03M | -0.13% | 111,237 | 9.01M |
| 264 | FHTX | Foghorn Therapeutics Inc. | 365.79M | 0.97% | 144,153 | 28.22M |
| 265 | FENC | Fennec Pharmaceuticals Inc. | 359.18M | 0.88% | 24,940 | 51.00M |
| 266 | FATE | Fate Therapeutics, Inc. | 354.92M | 3.92% | 1,825,174 | 6.32M |
| 267 | LYEL | Lyell Immunopharma, Inc. | 354.44M | -1.36% | 60,186 | 31.00K |
| 268 | IMRX | Immuneering Corporation | 351.95M | -1.63% | 485,411 | - |
| 269 | IKT | Inhibikase Therapeutics, Inc. | 336.58M | -4.59% | 235,272 | 1.00 |
| 270 | PALI | Palisade Bio, Inc. | 335.01M | -5.85% | 2,413,778 | - |
| 271 | IRD | Opus Genetics, Inc. | 332.74M | -1.71% | 342,444 | 11.98M |
| 272 | ZNTL | Zentalis Pharmaceuticals, Inc. | 329.95M | -4.63% | 283,485 | 26.87M |
| 273 | OABI | OmniAb, Inc. | 328.36M | -1.52% | 193,504 | 28.94M |
| 274 | LCTX | Lineage Cell Therapeutics, Inc. | 317.86M | -4.85% | 551,949 | 14.78M |
| 275 | ELDN | Eledon Pharmaceuticals, Inc. | 313.85M | -3.56% | 615,152 | - |
| 276 | IFRX | InflaRx N.V. | 305.63M | -3.94% | 382,072 | 33.82K |
| 277 | GALT | Galectin Therapeutics Inc. | 302.28M | 1.77% | 229,995 | - |
| 278 | SABS | SAB Biotherapeutics, Inc. | 298.21M | 3.45% | 189,771 | 114.70K |
| 279 | NMRA | Neumora Therapeutics, Inc. | 296.71M | 0.72% | 324,981 | - |
| 280 | GLSI | Greenwich LifeSciences, Inc. | 296.50M | 7.05% | 77,164 | - |
| 281 | RNAC | Cartesian Therapeutics, Inc. | 294.70M | -2.15% | 38,144 | 1.78M |
| 282 | BCYC | Bicycle Therapeutics plc | 293.21M | -1.87% | 212,023 | 63.50M |
| 283 | ALXO | ALX Oncology Holdings Inc. | 292.00M | -6.87% | 352,305 | - |
| 284 | MGNX | MacroGenics, Inc. | 287.31M | -3.00% | 235,118 | 157.08M |
| 285 | INDP | Indaptus Therapeutics, Inc. | 275.18M | -0.82% | 21,018 | - |
| 286 | SRZN | Surrozen, Inc. | 271.19M | 2.09% | 44,022 | 7.49M |
| 287 | NAGE | Niagen Bioscience, Inc. | 270.56M | 0.59% | 306,809 | 130.42M |
| 288 | ADAG | Adagene Inc. | 264.79M | 4.63% | 47,553 | 7.67M |
| 289 | CNXU | Conexeu Sciences Inc. | 261.43M | -4.59% | 46,118 | - |
| 290 | TRDA | Entrada Therapeutics, Inc. | 261.24M | -0.96% | 123,656 | 5.74M |
| 291 | NKTX | Nkarta, Inc. | 259.72M | -1.09% | 246,288 | - |
| 292 | ACIU | AC Immune SA | 253.95M | 1.59% | 99,932 | 4.62M |
| 293 | TTRX | Turn Therapeutics Inc. | 249.92M | -8.71% | 103,370 | - |
| 294 | AVXL | Anavex Life Sciences Corp. | 247.90M | -0.93% | 286,873 | - |
| 295 | CHRS | Coherus Oncology, Inc. | 246.80M | -3.03% | 764,208 | 46.88M |
| 296 | SLGL | Sol-Gel Technologies Ltd. | 245.17M | 0.32% | 10,779 | 18.47M |
| 297 | IVVD | Invivyd, Inc. | 243.14M | -0.57% | 908,332 | 55.87M |
| 298 | FULC | Fulcrum Therapeutics, Inc. | 239.21M | -3.75% | 478,840 | 80.00M |
| 299 | NAUT | Nautilus Biotechnology, Inc. | 238.91M | 5.62% | 1,419,995 | - |
| 300 | CGEN | Compugen Ltd. | 238.35M | 4.56% | 231,044 | 72.66M |
| 301 | PRQR | ProQR Therapeutics N.V. | 237.08M | - | 770,776 | 15.73M |
| 302 | CDXS | Codexis, Inc. | 234.97M | -0.58% | 228,692 | 78.09M |
| 303 | KPTI | Karyopharm Therapeutics Inc. | 233.20M | -3.56% | 129,733 | 151.12M |
| 304 | OBIO | Orchestra BioMed Holdings, Inc. | 232.94M | -0.77% | 102,785 | 32.72M |
| 305 | KROS | Keros Therapeutics, Inc. | 231.96M | 0.43% | 105,479 | 33.18M |
| 306 | DTIL | Precision BioSciences, Inc. | 231.19M | -3.45% | 366,226 | 45.07M |
| 307 | TARA | Protara Therapeutics, Inc. | 230.44M | -0.24% | 75,287 | - |
| 308 | QTTB | Q32 Bio Inc. | 226.37M | -5.18% | 81,751 | 53.74M |
| 309 | CAMP | Camp4 Therapeutics Corporation | 224.32M | 3.10% | 52,713 | 3.93M |
| 310 | RNA | Atrium Therapeutics, Inc. | 222.37M | -2.77% | 50,962 | 36.68M |
| 311 | VYGR | Voyager Therapeutics, Inc. | 219.33M | -2.68% | 151,233 | 36.49M |
| 312 | NERV | Minerva Neurosciences, Inc. | 219.20M | 1.84% | 44,091 | - |
| 313 | NBP | NovaBridge Biosciences | 219.15M | -1.81% | 331,871 | - |
| 314 | CLLS | Cellectis S.A. | 219.02M | 1.94% | 547 | 75.11M |
| 315 | WHWK | Whitehawk Therapeutics, Inc. | 212.44M | -0.25% | 195,383 | 7.15M |
| 316 | OTLK | Outlook Therapeutics, Inc. | 207.28M | 1.48% | 7,112,122 | 333.14K |
| 317 | KRRO | Korro Bio, Inc. | 202.06M | -4.82% | 69,560 | 3.84M |
| 318 | NGEN | NervGen Pharma Corp. | 201.79M | 2.70% | 228,790 | - |
| 319 | IMUX | Immunic, Inc. | 201.60M | 0.20% | 39,852 | - |
| 320 | ARCT | Arcturus Therapeutics Holdings Inc. | 197.82M | -4.66% | 310,137 | 54.71M |
| 321 | HUMA | Humacyte, Inc. | 197.64M | -0.03% | 5,414,145 | 2.02M |
| 322 | EQ | Equillium, Inc. | 197.27M | -0.95% | 254,913 | 4.39M |
| 323 | ABOS | Acumen Pharmaceuticals, Inc. | 197.18M | - | 148,626 | - |
| 324 | TNXP | Tonix Pharmaceuticals Holding Corp. | 195.27M | -4.15% | 184,816 | 17.56M |
| 325 | PLX | Protalix BioTherapeutics, Inc. | 193.77M | 1.05% | 248,476 | 76.38M |
| 326 | TNYA | Tenaya Therapeutics, Inc. | 192.43M | 0.78% | 2,085,485 | 225.00K |
| 327 | ALEC | Alector, Inc. | 189.85M | -6.56% | 282,695 | 18.42M |
| 328 | MDWD | MediWound Ltd. | 186.87M | -1.09% | 11,306 | 14.48M |
| 329 | ARMP | Armata Pharmaceuticals, Inc. | 185.76M | -0.78% | 100,840 | 5.20M |
| 330 | CRBU | Caribou Biosciences, Inc. | 185.47M | -3.61% | 1,143,769 | 11.20M |
| 331 | LENZ | LENZ Therapeutics, Inc. | 183.42M | -4.57% | 289,608 | 20.99M |
| 332 | ACOG | Alpha Cognition Inc. | 181.70M | -1.82% | 17,133 | 10.83M |
| 333 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 177.50M | 0.31% | 67,110 | - |
| 334 | OKUR | OnKure Therapeutics, Inc. | 177.34M | -2.01% | 27,570 | - |
| 335 | ORMP | Oramed Pharmaceuticals Inc. | 172.30M | -1.86% | 152,731 | 2.00M |
| 336 | MIST | Milestone Pharmaceuticals Inc. | 170.74M | 2.87% | 286,906 | 1.78M |
| 337 | IPHA | Innate Pharma S.A. | 170.31M | -0.54% | 849 | 10.57M |
| 338 | ANTX | AN2 Therapeutics, Inc. | 167.48M | 5.44% | 32,648 | - |
| 339 | CNTN | Canton Strategic Holdings, Inc. | 167.18M | 3.23% | 282,226 | - |
| 340 | PYXS | Pyxis Oncology, Inc. | 165.67M | -2.79% | 270,697 | 13.86M |
| 341 | TLSA | Tiziana Life Sciences Ltd | 165.51M | 2.40% | 36,528 | - |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 163.66M | -0.38% | 405,631 | 2.29M |
| 343 | MENS | Jyong Biotech Ltd. | 163.31M | - | 31,521 | - |
| 344 | CNTB | Connect Biopharma Holdings Limited | 161.50M | 15.54% | 1,639,766 | 233.00K |
| 345 | KZIA | Kazia Therapeutics Limited | 149.52M | 5.02% | 56,546 | 1.27M |
| 346 | MOLN | Molecular Partners AG | 148.70M | - | - | 856.30K |
| 347 | HURA | TuHURA Biosciences, Inc. | 147.74M | 1.75% | 103,110 | - |
| 348 | UNCY | Unicycive Therapeutics, Inc. | 143.11M | -1.29% | 517,124 | - |
| 349 | CBUS | Cibus, Inc. | 140.83M | 1.37% | 353,751 | 4.29M |
| 350 | YDES | YD Bio Limited | 139.28M | 1.06% | 21,288 | 510.36K |
| 351 | SPRB | Spruce Biosciences, Inc. | 138.26M | 0.87% | 29,196 | 697.00K |
| 352 | AGEN | Agenus Inc. | 137.00M | 1.23% | 422,573 | 123.87M |
| 353 | PEPG | PepGen Inc. | 136.96M | -0.50% | 465,480 | - |
| 354 | VANI | Vivani Medical, Inc. | 135.82M | -1.56% | 658,014 | - |
| 355 | NMAD | NOMAD Power Solutions, Inc. | 135.31M | -4.18% | 113,321 | - |
| 356 | CUE | Cue Biopharma, Inc. | 133.70M | -9.96% | 68,373 | 32.73M |
| 357 | GNLX | Genelux Corporation | 130.56M | -0.68% | 49,598 | 8.00K |
| 358 | COYA | Coya Therapeutics, Inc. | 126.67M | 0.75% | 118,203 | 7.94M |
| 359 | PMN | ProMIS Neurosciences, Inc. | 125.95M | 1.92% | 5,469 | - |
| 360 | ENGN | enGene Therapeutics Inc. | 125.27M | 0.54% | 648,542 | - |
| 361 | ALDX | Aldeyra Therapeutics, Inc. | 124.86M | -2.82% | 518,171 | - |
| 362 | GUTS | Fractyl Health, Inc. | 124.46M | 2.94% | 294,076 | 3.00K |
| 363 | SPRO | Spero Therapeutics, Inc. | 124.20M | -1.15% | 81,071 | 61.19M |
| 364 | SEER | Seer, Inc. | 120.13M | 0.23% | 161,338 | 15.17M |
| 365 | PLYX | Polaryx Therapeutics, Inc. | 118.83M | -1.57% | 66,348 | - |
| 366 | ENLV | Enlivex Ltd. | 118.76M | 2.53% | 69,272 | - |
| 367 | NTHI | NeOnc Technologies Holdings, Inc. | 114.24M | -1.89% | 8,192 | 39.99K |
| 368 | KLRS | Kalaris Therapeutics, Inc. | 109.80M | -2.02% | 5,503 | - |
| 369 | VRCA | Verrica Pharmaceuticals Inc. | 108.05M | -4.98% | 5,437 | 37.16M |
| 370 | BDTX | Black Diamond Therapeutics, Inc. | 108.01M | -0.79% | 323,075 | 70.00M |
| 371 | ANIX | Anixa Biosciences, Inc. | 107.17M | 1.29% | 49,070 | - |
| 372 | FBIO | Fortress Biotech, Inc. | 106.63M | 7.00% | 684,574 | 66.16M |
| 373 | AARD | Aardvark Therapeutics, Inc. | 104.17M | -9.56% | 114,249 | - |
| 374 | ONCY | Oncolytics Biotech Inc. | 103.16M | 9.09% | 13,236 | - |
| 375 | PYPD | PolyPid Ltd. | 101.43M | 1.54% | 138,705 | - |
| 376 | ICCC | ImmuCell Corporation | 100.87M | 4.89% | 26,497 | 29.93M |
| 377 | INO | Inovio Pharmaceuticals, Inc. | 97.91M | -1.65% | 662,792 | 65.34K |
| 378 | ATHE | Alterity Therapeutics Limited | 96.97M | -3.58% | 12,485 | 4.43M |
| 379 | PTHS | Pelthos Therapeutics Inc. | 95.89M | -1.46% | 7,320 | 27.70M |
| 380 | ALPS | Alps Group Inc | 95.01M | -1.81% | 31,446 | 3.74M |
| 381 | ACET | Adicet Bio, Inc. | 93.83M | -3.41% | 39,324 | - |
| 382 | CGTX | Cognition Therapeutics, Inc. | 93.08M | -2.80% | 891,033 | - |
| 383 | BMEA | Biomea Fusion, Inc. | 92.90M | -1.15% | 272,991 | - |
| 384 | CRDF | Cardiff Oncology, Inc. | 89.91M | 5.20% | 315,460 | 525.00K |
| 385 | RNTX | Rein Therapeutics Inc. | 89.20M | -1.16% | 151,886 | - |
| 386 | NRXS | NeurAxis, Inc. | 88.12M | 0.49% | 10,925 | 4.28M |
| 387 | OKYO | OKYO Pharma Limited | 87.90M | 0.90% | 59,971 | - |
| 388 | ATRA | Atara Biotherapeutics, Inc. | 87.58M | 0.73% | 23,834 | 23.14M |
| 389 | MAIA | MAIA Biotechnology, Inc. | 87.25M | -2.38% | 287,218 | - |
| 390 | ACRV | Acrivon Therapeutics, Inc. | 86.46M | -0.98% | 262,084 | - |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 85.97M | 0.81% | 39,019 | - |
| 392 | RANI | Rani Therapeutics Holdings, Inc. | 85.45M | -0.46% | 302,426 | 3.17M |
| 393 | LONA | LeonaBio, Inc. | 84.82M | 4.15% | 1,134 | - |
| 394 | RLYB | Rallybio Corporation | 83.92M | 1.02% | 7,054 | 858.00K |
| 395 | GOSS | Gossamer Bio, Inc. | 83.69M | 1.30% | 3,314,087 | 55.54M |
| 396 | ENTX | Entera Bio Ltd. | 83.30M | - | 60,616 | 42.00K |
| 397 | CSBR | Champions Oncology, Inc. | 82.77M | -1.75% | 1,920 | 57.95M |
| 398 | HRTX | Heron Therapeutics, Inc. | 82.47M | -2.20% | 495,802 | 150.71M |
| 399 | ANVS | Annovis Bio, Inc. | 82.32M | -2.76% | 474,024 | - |
| 400 | GANX | Gain Therapeutics, Inc. | 76.99M | 0.84% | 370,944 | - |
| 401 | IBIO | iBio, Inc. | 76.01M | 0.66% | 441,614 | 300.00K |
| 402 | OSTX | OS Therapies Incorporated | 74.38M | 14.38% | 832,365 | - |
| 403 | HYFT | MindWalk Holdings Corp. | 74.00M | 3.47% | 34,170 | 20.70M |
| 404 | XBIT | XBiotech Inc. | 70.12M | -2.54% | 22,860 | - |
| 405 | TCRX | TScan Therapeutics, Inc. | 69.93M | -15.08% | 789,179 | 9.14M |
| 406 | PLRX | Pliant Therapeutics, Inc. | 68.82M | -1.75% | 840,766 | - |
| 407 | MNOV | MediciNova, Inc. | 67.98M | -1.34% | 17,479 | 596.64K |
| 408 | IMA | ImageneBio, Inc. | 66.10M | -1.10% | 1,677 | 800.00K |
| 409 | PMVP | PMV Pharmaceuticals, Inc. | 65.86M | -1.20% | 60,784 | - |
| 410 | CING | Cingulate Inc. | 65.59M | 0.62% | 93,314 | - |
| 411 | MCRB | Seres Therapeutics, Inc. | 65.27M | -5.60% | 84,191 | 1.15M |
| 412 | VRXA | Veraxa Biotech AG | 65.06M | -6.52% | 352,023 | - |
| 413 | ELTX | Elicio Therapeutics, Inc. | 64.84M | -2.58% | 510,537 | - |
| 414 | EXOZ | eXoZymes, Inc. | 64.02M | - | 2,617 | -700.00 |
| 415 | EDSA | Edesa Biotech, Inc. | 63.31M | -2.60% | 43,894 | - |
| 416 | BYSI | BeyondSpring Inc. | 61.68M | -10.18% | 62,110 | 1.88M |
| 417 | ATYR | aTyr Pharma, Inc. | 59.55M | -5.57% | 880,619 | 190.00K |
| 418 | FLNA | Filana Therapeutics, Inc. | 57.42M | 0.74% | 320,504 | - |
| 419 | BOLD | Boundless Bio, Inc. | 56.27M | 2.24% | 62,044 | - |
| 420 | XLO | Xilio Therapeutics, Inc. | 55.10M | -0.75% | 10,519 | 53.48M |
| 421 | INKT | MiNK Therapeutics, Inc. | 54.55M | 3.79% | 5,251 | - |
| 422 | IMMP | Immutep Limited | 53.99M | -1.68% | 64,417 | 5.28M |
| 423 | CNTX | Context Therapeutics Inc. | 53.38M | -2.45% | 3,056,129 | - |
| 424 | TIL | Instil Bio, Inc. | 53.37M | 1.16% | 10,298 | - |
| 425 | MREO | Mereo BioPharma Group plc | 51.51M | 2.12% | 294,806 | 500.00K |
| 426 | IBO | Impact BioMedical Inc. | 49.49M | 1.62% | 12,916 | 39.00K |
| 427 | RADX | Radiopharm Theranostics Limited | 49.00M | -2.45% | 12,865 | 10.86M |
| 428 | CRVO | CervoMed Inc. | 47.48M | 2.93% | 146,584 | 2.09M |
| 429 | MGX | Metagenomi Therapeutics, Inc. | 47.44M | -2.33% | 174,366 | 22.33M |
| 430 | DWTX | Dogwood Therapeutics, Inc. | 47.42M | - | 16,093 | - |
| 431 | HYPD | Hyperion DeFi, Inc. | 46.38M | 3.03% | 81,430 | 1.04M |
| 432 | VERU | Veru Inc. | 45.10M | 5.64% | 67,739 | 16.89M |
| 433 | ELOX | Eloxx Pharmaceuticals, Inc. | 44.40M | -10.20% | 69,658 | - |
| 434 | INMB | INmune Bio Inc. | 44.40M | -2.91% | 619,362 | 50.00K |
| 435 | PDSB | PDS Biotechnology Corporation | 43.70M | -5.08% | 295,541 | - |
| 436 | ALGS | Aligos Therapeutics, Inc. | 42.39M | 1.78% | 97,360 | 4.71M |
| 437 | ABVC | ABVC BioPharma, Inc. | 42.20M | -17.33% | 250,092 | 797.92K |
| 438 | LTRN | Lantern Pharma Inc. | 41.59M | 5.16% | 166,795 | - |
| 439 | APLM | Apollomics, Inc. | 41.14M | -1.97% | 1,016 | 8.84M |
| 440 | RNXT | RenovoRx, Inc. | 40.59M | 0.01% | 32,175 | 1.49M |
| 441 | GRCE | Grace Therapeutics, Inc. | 40.52M | - | 41,839 | - |
| 442 | DYAI | Dyadic International, Inc. | 38.63M | 6.33% | 119,902 | 3.81M |
| 443 | ESLA | Estrella Immunopharma, Inc. | 38.30M | -1.10% | 5,612 | - |
| 444 | GNTA | Genenta Science S.p.A. | 37.51M | 3.92% | 40,239 | - |
| 445 | TVRD | Tvardi Therapeutics, Inc. | 37.24M | -20.60% | 4,987,760 | - |
| 446 | NNVC | NanoViricides, Inc. | 37.13M | 5.16% | 237,058 | - |
| 447 | NTRB | Nutriband Inc. | 35.86M | -3.59% | 6,010 | 1.80M |
| 448 | LITS | Lite Strategy, Inc. | 33.90M | 2.00% | 53,158 | - |
| 449 | SER | Serina Therapeutics, Inc. | 32.99M | 10.00% | 30,303 | 130.00K |
| 450 | SNTI | Senti Biosciences Holdings, Inc. | 32.74M | 1.07% | 50,802 | 38.00K |
| 451 | BCTX | BriaCell Therapeutics Corp. | 32.33M | -2.43% | 78,851 | - |
| 452 | ATNM | Actinium Pharmaceuticals, Inc. | 31.37M | 3.06% | 9,988 | 90.00K |
| 453 | DARE | Daré Bioscience, Inc. | 31.01M | 1.97% | 69,531 | 1.16M |
| 454 | ACTU | Actuate Therapeutics, Inc. | 30.62M | -3.77% | 349,784 | - |
| 455 | KYNB | Kyntra Bio, Inc. | 30.08M | -0.80% | 11,570 | 7.44M |
| 456 | LSTA | Lisata Therapeutics, Inc. | 29.50M | 0.93% | 3,503 | 170.00K |
| 457 | GRDX | GridAI Technologies Corp. | 28.38M | -0.81% | 6,943 | - |
| 458 | IGC | IGC Pharma, Inc. | 27.62M | 0.29% | 563,965 | 1.11M |
| 459 | PLRZ | Polyrizon Ltd. | 27.60M | 0.92% | 6,023 | - |
| 460 | PSTV | Plus Therapeutics, Inc. | 27.12M | 3.14% | 27,607 | 5.18M |
| 461 | EVAX | Evaxion A/S | 26.98M | -0.46% | 18,594 | 7.53M |
| 462 | MRKR | Marker Therapeutics, Inc. | 26.51M | -1.24% | 22,359 | 3.55M |
| 463 | KALA | KALA BIO, Inc. | 25.65M | -0.72% | 39,084 | - |
| 464 | NRSN | NeuroSense Therapeutics Ltd. | 25.09M | 0.17% | 44,939 | - |
| 465 | BRNS | Barinthus Biotherapeutics plc | 25.00M | -3.98% | 35,997 | 14.97M |
| 466 | SKYE | Skye Bioscience, Inc. | 24.73M | 0.09% | 37,858 | - |
| 467 | CVM | CEL-SCI Corporation | 23.59M | -4.26% | 122,898 | - |
| 468 | TVGN | Tevogen Bio Holdings Inc. | 23.41M | 7.50% | 3,859 | - |
| 469 | VYNE | VYNE Therapeutics Inc. | 22.65M | 4.43% | 21,653 | 454.00K |
| 470 | CELU | Celularity Inc. | 22.35M | 5.87% | 25,692 | 26.55M |
| 471 | AKTX | Akari Therapeutics, Plc | 21.88M | -12.03% | 12,538 | - |
| 472 | CLRB | Cellectar Biosciences, Inc. | 21.88M | 1.77% | 13,206 | - |
| 473 | NCEL | NewcelX Ltd. | 21.48M | -5.67% | 88,262 | - |
| 474 | LGVN | Longeveron Inc. | 20.56M | 1.20% | 91,736 | 1.22M |
| 475 | LPCN | Lipocine Inc. | 20.45M | 1.64% | 8,815 | 2.00M |
| 476 | QNTM | Quantum BioPharma Ltd. | 20.08M | 1.83% | 28,516 | - |
| 477 | ICU | SeaStar Medical Holding Corporation | 19.82M | -2.95% | 42,160 | 1.44M |
| 478 | PLUR | Pluri Inc. | 19.74M | -3.68% | 51,027 | 1.08M |
| 479 | ATOS | Atossa Therapeutics, Inc. | 19.63M | -6.94% | 105,614 | - |
| 480 | NEUP | Neuphoria Therapeutics Inc. | 19.02M | - | 29,785 | -13.27K |
| 481 | ALLR | Allarity Therapeutics, Inc. | 18.62M | 0.86% | 29,191 | 345.00K |
| 482 | PTN | Palatin Technologies, Inc. | 18.45M | -0.10% | 2,593 | 12.88M |
| 483 | HOWL | Werewolf Therapeutics, Inc. | 17.35M | -0.78% | 105,735 | 1.14M |
| 484 | QNCX | Quince Therapeutics, Inc. | 16.80M | -0.41% | 4,187 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 16.74M | -2.05% | 109,991 | - |
| 486 | CYCN | Cyclerion Therapeutics, Inc. | 16.67M | 13.09% | 43,940 | 1.99M |
| 487 | BIVI | BioVie Inc. | 16.48M | 0.23% | 39,155 | - |
| 488 | GTBP | GT Biopharma, Inc. | 15.91M | -5.65% | 498,124 | - |
| 489 | CTXR | Citius Pharmaceuticals, Inc. | 15.50M | 1.29% | 117,395 | 5.61M |
| 490 | AEON | AEON Biopharma, Inc. | 15.15M | -17.79% | 303,356 | - |
| 491 | HIND | Vyome Holdings, Inc. | 15.09M | 0.94% | 19,121 | 152.72K |
| 492 | MLEC | Moolec Science SA | 15.02M | -6.70% | 1,654 | 7.83M |
| 493 | PASG | Passage Bio, Inc. | 14.92M | -3.53% | 14,083 | - |
| 494 | LEXX | Lexaria Bioscience Corp. | 14.88M | -0.79% | 23,294 | 368.00K |
| 495 | JSPR | Jasper Therapeutics, Inc. | 14.79M | 2.66% | 194,680 | - |
| 496 | CALC | CalciMedica, Inc. | 14.49M | 1.93% | 146,631 | - |
| 497 | TPST | Tempest Therapeutics, Inc. | 14.36M | -1.75% | 28,188 | - |
| 498 | COCP | Cocrystal Pharma, Inc. | 13.91M | 2.75% | 11,327 | 225.00K |
| 499 | INAB | IN8bio, Inc. | 13.79M | 1.45% | 49,473 | - |
| 500 | CMMB | Chemomab Therapeutics Ltd. | 13.75M | -3.05% | 165,894 | - |